Rigel Pharmaceuticals Inc vs Taiwan Semiconductor Manufacturing
A head-to-head of Rigel Pharmaceuticals Inc (RIGL) and Taiwan Semiconductor Manufacturing (TSM) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | RIGL | TSM |
|---|---|---|
| Market Cap | $564.75M | $2.03T |
| P/E (TTM) | 1.50 | 33.08 |
| Forward P/E | 6.45 | 27.03 |
| P/S | 1.92 | 0.50 |
| P/B | 1.41 | 10.89 |
| EV/EBITDA | 3.51 | 24.68 |
| Dividend Yield | — | 0.37% |
| Profit Margin | 124.72% | 47.01% |
| Gross Margin | 93.33% | 59.89% |
| Operating Margin | 42.63% | 50.82% |
| Revenue Growth (YoY) | +21.19% | +36.53% |
| FCF Yield | 13.40% | 54.16% |
| Debt / Equity | 13.51 | 17.87 |
| Current Ratio | 2.42 | 2.49 |
Share:
Compare Rigel Pharmaceuticals Inc with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.